SP 500 Gains as Healthcare and Tech Outperform Communication Services Lags Money Market Account Rates on May 25 2026 Top Yields Reach 401 APY Google Revives Smart Glasses Ambitions with New AIPowered Wearable Jim Cramer Weighs In on Atlassians YouTube Controversy What Investors Should Know EU and Mexico Strengthen Trade Alliance to Reduce Dependence on Major Economies Market Expert Sunil Subramaniam Points to Q1 Earnings as Key Driver Amid Geopolitical and Cost Pressures MOMO Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower Biogen Q1 2026 Earnings Strong EPS Surprise of 2634 Boosts Investor Confidence JOUT Q1 2026 Earnings Earnings Beat Amidst Challenging Outdoor Market Conditions Definitive Healthcare Corp DH Q1 2026 Earnings EPS Surge Beats Expectations Stock Climbs BMNR Q1 2026 Earnings EPS Surprise as Company Reports Profitability TEO Q1 2026 Earnings Massive EPS Beat as Telecom Argentina Reports Stellar Results Plumas Bancorp PLBC Holds Gains in Quiet Session Support and Resistance Levels in Focus Sleep Number Stock Hovers Near Support as Traders Eye Key Levels iRadimed Corporation IRMD Holds Steady Near Key Support A Technical and Fundamental Review Berto Acquisition Corp Warrant TACOW Edges Higher as Price Tests Resistance Near 072 Red Cat Holdings RCAT Surges Over 24 as Drone Sector Momentum Builds Micron Shares Surge 18 as Company Reportedly Reaches 1 Trillion Market Cap Mesoblast Q1 2026 Earnings Narrower Loss Surprises on Cost Discipline Stock Gains Andretti Acquisition Corp II Warrant POLEW Holds Steady Near Support at 025 JD Q1 2026 Earnings EPS Misses Estimates Stock Dips 3 Capital City Bank Group CCBG Q1 2026 Earnings EPS Surges Past Estimates Amid Solid Core Operations Home BancShares Inc HOMB Q1 2026 Earnings EPS Slightly Misses Estimates Stock Holds Steady Chubb Limited CB Q1 2026 Earnings Slight EPS Beat Amid Modest Market Pullback PERF Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability Dyne Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Drives Slight Stock Uptick PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline